News

This expanded effort will be conducted at Purdue University’s Bindley Bioscience Center, and will focus on further validating targeted, systemically delivered cancer therapies utilizing Kylin’s proprietary pRNAi platform.

Recently approved by the FDA, the Talent thoracic stent graft with the new delivery system is now available to physicians across the US. The Talent thoracic stent graft

The TomoTherapy Hi Art treatment system is said to be the only radiation therapy solution to use a CT-style ring gantry design, CT-based image guidance and two distinct

The technology will permit MDRNA to stabilize and provide drug-like properties to RISC and Dicer length small interfering RNAs (siRNAs) in a novel and proprietary manner. Terms of

The FDA also granted traditional (full) approval to Prezista as twice-daily for use in treatment-experienced adult patients. Prezista was developed by Tibotec Pharmaceuticals and is marketed in the

Merit Medical Systems said that this device, which is used primarily for access to dialysis fistulas and grafts, provides several advantages for clinicians, including a marker tip to

Mr Geisenheimer’s appointment follows the resignation of John Schulte as president and CEO and as a director of the company. Three additional employees have also left the company.

According to the company, IntuiTrak has a novel design and deployment mechanism that simplifies delivery of the unibody bifurcated Powerlink device. The low-profile delivery system features enhanced flexibility,

The study has demonstrated a statistically significant reduction in the number of inflammatory lesions from baseline with the median reduction at three weeks after the final treatment of